Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
What the clinical trial data shows Weight loss SURMOUNT-5 SURMOUNT-5 enrolled 751 adults with obesity but without type 2 diabetes and assigned them to the maximum tolerated dose of either tirzepatide (10 mg or 15 mg) or semaglutide (1.7 mg or 2.4 mg) for 72 weeks
Lower GLP-1 use among adults ages 65 and older, including for weight loss, may reflect Medicares lack of coverage for prescription drugs used specifically for weight loss
It also functions as an antioxidant to decrease free radicals
This allows for rapid and efficient absorption into the bloodstream
US$ 23.13
US$ 25.36
US$ 21.72
US$ 29.23
US$ 29.82
US$ 22.75
US$ 29.34
US$ 29.21
US$ 23.54
